FIELD: pharmacology.
SUBSTANCE: invention describes rectal suppositories for treatment of prostate diseases, particularly chronic prostatitis, including chronic abacterial prostatitis (HAP), prostatic hyperplasia, benign prostatic hyperplasia, and for treatment of pre-and postoperative prostate conditions. Suppositories contain lysyl-glutamyl-aspartyl-proline tetrapeptide (0.0003-0.0010 grams), dimethylsulfoxide (0.014-0.05 g) and a base for suppositories in an amount sufficient to produce a suppository weighing 1.0 g.
EFFECT: suppositories are stable during storage and highly effective for treatment of prostate diseases.
5 cl, 1 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAPEPTIDE REGULATING PROSTATE FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2001 |
|
RU2177802C1 |
| COMPLEX NATURAL PREPARATION AS SUPPOSITORY FOR TREATMENT OF PATIENT WITH UROLOGICAL, PROCTOLOGICAL AND GYNECOLOGICAL DISEASES AND METHOD OF ITS PREPARING | 1998 |
|
RU2146920C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| AGENT FOR REDUCING PATHOLOGICAL CHANGES IN PROSTATIC HYPERPLASIA | 2020 |
|
RU2740946C1 |
| METHOD OF TREATING PROSTATE ADENOMA COMBINED WITH CHRONIC NONBACTERIAL PROSTATITIS | 2014 |
|
RU2568369C1 |
| METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA | 2009 |
|
RU2408399C1 |
| MEDICAL PRODUCT AND MEDICINAL COMPOSITION FOR MANUFACTURING THEREOF | 2008 |
|
RU2372933C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
| METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2478408C1 |
| METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS | 2012 |
|
RU2479331C1 |
